![Geoffrey J. Filbey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Geoffrey J. Filbey
Plus aucun poste en cours
Profil
Geoffrey J.
Filbey joined Biopure Corp.
in 1985 and has been Vice President of Engineering since 1995.
He was a Project Manager and Process Engineer of Stone & Webster Engineering Corporation for 14 years.
Mr. Filbey received a BS degree in Engineering from the City University.
Anciens postes connus de Geoffrey J. Filbey
Sociétés | Poste | Fin |
---|---|---|
Biopure Corp.
![]() Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | 12/05/2008 |
Formation de Geoffrey J. Filbey
City University of New York | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Biopure Corp.
![]() Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Health Technology |